Lurdes Zamora - Concepedia

Author

Lurdes Zamora

Also Known As

Eduardo Salido, Evarist Feliu, J Hernandez, Jordi Ribera, L Zamora, L. Calderón Zamora, L. Zamora, Lourdes Zamora, Lurdes Zamora, M. Buschbeck

258

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

Universitat Autònoma de Barcelona Josep Carreras Leukaemia Research Institute Duran i Reynals Hospital Institut Català d'Oncologia Hospital Universitari Germans Trias i Pujol

About

Lurdes Zamora is an author at Universitat Autònoma de Barcelona specializing in medicine, hematology, and molecular diagnostics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	1K
2	Health Sciences	7	7	110
3	Natural Sciences	1	1	26
4	Public Health	1	1	746
5	Biochemistry	1	1	26

Lurdes Zamora

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes Elsa Bernard, Heinz Tuechler, Peter L. Greenberg, NEJM Evidence Mixed-phenotype Acute LeukemiaPrognosisGenetic EpidemiologyDiagnosisPathology	2022	746
Activating Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor Are Associated with Improved Survival in Gefitinib-Treated Chemorefractory Lung Adenocarcinomas Miguel Tarón, Yukito Ichinose, Rafael Rosell, Clinical Cancer Research	2005	336
Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms Laura Palomo, Manja Meggendorfer, Stephan Hütter, Blood	2020	178
Genetic Imbalances in Progressed B-Cell Chronic Lymphocytic Leukemia and Transformed Large-Cell Lymphoma (Richter's Syndrome) Armando López‐Guillermo, Maria Ribas, Xavier Puig, American Journal Of Pathology Hematological MalignancyLymphoid NeoplasiaTransformed Large-cell LymphomaGeneticsImmunology	2002	100
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia Josep‐María Ribera, Mireia Morgades, Juana Ciudad, Blood	2020	80
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol Álex Bataller, Ana Garrido, Francesca Guijarro, Blood Advances	2021	54
Prognostic significance of copy number alterations in adolescent and adult patients with precursor <scp>B</scp> acute lymphoblastic leukemia enrolled in <scp>PETHEMA</scp> protocols Jordi Ribera, Mireia Morgades, Lurdes Zamora, Cancer	2015	52
Molecular taxonomy of myelodysplastic syndromes and its clinical implications Elsa Bernard, Robert P. Hasserjian, Peter L. Greenberg, Blood	2024	52
Molecular and clinical presentation of <i>UBA1</i>-mutated myelodysplastic syndromes Maria Sirenko, Elsa Bernard, Maria Creignou, Blood	2024	43
Comparison of flow‐FISH and MM–qPCR telomere length assessment techniques for the screening of telomeropathies Mónica S. Ventura Ferreira, Martin Kirschner, Insa Halfmeyer, Annals of the New York Academy of Sciences	2019	42

Page 1